NUAK Family Kinase 2 Is a Novel Therapeutic Target for Prostate Cancer

Scientists found that NUAK family kinase 2 (NUAK2) expression was elevated in prostate cancer and metastatic castration resistant PC versus normal tissue, and expression correlated with an increased risk of metastasis.